Pinnacle Financial Partners Inc Purchases 1,570 Shares of Kenvue Inc. (NYSE:KVUE)

Pinnacle Financial Partners Inc raised its stake in Kenvue Inc. (NYSE:KVUEFree Report) by 12.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,539 shares of the company’s stock after acquiring an additional 1,570 shares during the quarter. Pinnacle Financial Partners Inc’s holdings in Kenvue were worth $313,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of KVUE. Clearstead Advisors LLC bought a new position in Kenvue in the 3rd quarter valued at about $25,000. Planned Solutions Inc. bought a new position in Kenvue in the 4th quarter valued at about $27,000. AdvisorNet Financial Inc bought a new position in Kenvue in the 3rd quarter valued at about $28,000. Global Retirement Partners LLC bought a new position in Kenvue in the 3rd quarter valued at about $28,000. Finally, Venturi Wealth Management LLC bought a new position in Kenvue in the 3rd quarter valued at about $28,000. 97.64% of the stock is owned by institutional investors.

Kenvue Stock Performance

NYSE KVUE opened at $20.33 on Thursday. Kenvue Inc. has a 1 year low of $17.82 and a 1 year high of $27.80. The company has a current ratio of 1.12, a quick ratio of 0.78 and a debt-to-equity ratio of 0.69. The firm’s 50 day simple moving average is $20.04 and its 200 day simple moving average is $20.23.

Kenvue (NYSE:KVUEGet Free Report) last issued its earnings results on Thursday, February 8th. The company reported $0.31 earnings per share for the quarter, beating analysts’ consensus estimates of $0.28 by $0.03. Kenvue had a net margin of 9.87% and a return on equity of 15.62%. The firm had revenue of $3.67 billion for the quarter, compared to analyst estimates of $3.78 billion. The company’s quarterly revenue was down 2.7% compared to the same quarter last year. On average, equities analysts expect that Kenvue Inc. will post 1.17 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, February 28th. Shareholders of record on Wednesday, February 14th were given a $0.20 dividend. The ex-dividend date was Tuesday, February 13th. This represents a $0.80 dividend on an annualized basis and a yield of 3.94%.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. UBS Group increased their price target on shares of Kenvue from $20.00 to $23.00 and gave the company a “neutral” rating in a report on Tuesday, December 19th. Royal Bank of Canada decreased their target price on shares of Kenvue from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Friday, February 9th. William Blair started coverage on shares of Kenvue in a research report on Wednesday. They set a “market perform” rating on the stock. JPMorgan Chase & Co. decreased their target price on shares of Kenvue from $25.00 to $24.00 and set an “overweight” rating on the stock in a research report on Friday, February 9th. Finally, The Goldman Sachs Group started coverage on shares of Kenvue in a research report on Friday, March 1st. They set a “neutral” rating and a $20.00 target price on the stock. Eight research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, Kenvue has a consensus rating of “Hold” and an average price target of $25.42.

Read Our Latest Analysis on KVUE

About Kenvue

(Free Report)

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

See Also

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUEFree Report).

Institutional Ownership by Quarter for Kenvue (NYSE:KVUE)

Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.